Aspirus Regional Cancer Center — Wausau, Wisconsin

Aspirus Regional Cancer Center is a clinical research site located in Wausau, Wisconsin, United States 54401.

Crixeo Clinical Trials Trust Score: 33/100 (FAILING). This profile has not yet been claimed by the site owner.

Aspirus Regional Cancer Center has participated in 153 clinical trials with 85 currently active.

Therapeutic areas: Breast Cancer, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma.

Sponsors: NSABP Foundation Inc, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Wausau

Browse all research sites in Wisconsin · View every site in Wausau

Sponsor Feasibility Report

Trust Score: 33/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Aspirus Regional Cancer Center?

Aspirus Regional Cancer Center has a Crixeo Trust Score of 33/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Aspirus Regional Cancer Center conducted?

Aspirus Regional Cancer Center has 153 clinical trials on record, with 85 currently active. Their work covers Breast Cancer, Metastatic Lung Non-Squamous Non-Small Cell Carcinoma, Recurrent Lung Non-Squamous Non-Small Cell Carcinoma.

Is Aspirus Regional Cancer Center accredited by Crixeo Clinical Trials?

Aspirus Regional Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Aspirus Regional Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.